|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.06 CNY | +0.36% |
|
+0.23% | +6.52% |
| Apr. 27 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Mar. 24 | Henan Lingrui Pharmaceutical Gets China Approval for Antacid | MT |
| Capitalization | 12.42B 1.83B 1.57B 1.44B 1.37B 2.51B 175B 2.55B 17.23B 6.67B 83.14B 6.85B 6.7B 290B | P/E ratio 2026 * |
14.8x | P/E ratio 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise value | 12.32B 1.81B 1.56B 1.42B 1.36B 2.49B 174B 2.53B 17.08B 6.61B 82.43B 6.79B 6.65B 287B | EV / Sales 2026 * |
2.92x | EV / Sales 2027 * | 2.67x |
| Free-Float |
76.9% | Yield 2026 * |
5.44% | Yield 2027 * | 5.89% |
| 1 day | +0.36% | ||
| 1 week | +0.23% | ||
| Current month | -1.34% | ||
| 1 month | +4.65% | ||
| 3 months | +2.75% | ||
| 6 months | -0.63% | ||
| Current year | +6.52% |
| 1 week | 21.5 |  | 22.31 |
| 1 month | 21 | | 22.93 |
| Current year | 20.73 | | 22.93 |
| 1 year | 20.3 | | 24.94 |
| 3 years | 14.3 | | 27.26 |
| 5 years | 9.3 | | 27.26 |
| 10 years | 6.81 | | 27.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 42 | 2014-06-05 |
Peng Yu
DFI | Director of Finance/CFO | 57 | 2020-06-05 |
Jia Shu Jiang
PRN | Corporate Officer/Principal | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xi Zhen Wu
BRD | Director/Board Member | 62 | 2006-04-17 |
Zi Run Pan
BRD | Director/Board Member | 54 | 2020-06-04 |
Wei Xiong
CHM | Chairman | 42 | 2019-04-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +0.23% | -7.00% | +35.75% | 1.83B | |
| -1.17% | -3.27% | -10.28% | -11.42% | 13.35B | |
| -0.94% | -1.52% | -27.53% | -53.41% | 5.5B | |
| -1.77% | -2.61% | -7.98% | +6.91% | 4.93B | |
| -2.00% | +1.14% | +37.36% | -11.61% | 4.23B | |
| -1.84% | -4.62% | +8.61% | -43.31% | 4.06B | |
| -2.38% | -1.26% | +5.21% | -8.51% | 3.83B | |
| -0.95% | -2.07% | -9.35% | -1.74% | 3.21B | |
| -2.65% | -1.68% | -1.68% | -25.88% | 2.45B | |
| +0.13% | -2.96% | -12.60% | -3.04% | 1.86B | |
| Average | -1.32% | -2.67% | -2.52% | -11.63% | 4.52B | |
| Weighted average by Cap. | -1.40% | -2.88% | -4.10% | -15.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.21B 619M 533M 487M 465M 852M 59.41B 866M 5.84B 2.26B 28.2B 2.32B 2.27B 98.25B | 4.56B 671M 577M 528M 503M 923M 64.34B 938M 6.33B 2.45B 30.54B 2.52B 2.46B 106B |
| Net income | 846M 124M 107M 97.81M 93.32M 171M 11.93B 174M 1.17B 454M 5.66B 467M 457M 19.73B | 931M 137M 118M 108M 103M 188M 13.13B 191M 1.29B 500M 6.23B 513M 502M 21.71B |
| Net Debt | -106M -15.58M -13.4M -12.25M -11.69M -21.43M -1.49B -21.79M -147M -56.89M -709M -58.45M -57.2M -2.47B | -249M -36.59M -31.48M -28.79M -27.47M -50.35M -3.51B -51.18M -345M -134M -1.67B -137M -134M -5.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 22.06 ¥ | +0.36% | 10,082,150 |
| 26-05-14 | 21.98 ¥ | +0.78% | 6,966,023 |
| 26-05-13 | 21.81 ¥ | +0.14% | 5,876,132 |
| 26-05-12 | 21.78 ¥ | -0.23% | 10,654,930 |
| 26-05-11 | 21.83 ¥ | -0.82% | 8,194,580 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600285 Stock
Select your edition
All financial news and data tailored to specific country editions
